Overview

A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy

Status:
Unknown status
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
This is a study aiming to assess the efficacy and safety of Keluo Xin capsule in patients with moderately severe to severe nonproliferative diabetic retinopathy (NPDR). Two-thirds of participates will receive Keluo Xin capsules while other one third will receive placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Chengdu Kanghong Pharmaceutical Co., Ltd.